Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(Z)-1-(N-(2-aminoethyl)-N-(2-ammonioethyl)amino)diazen-1-ium-1,2-diolate | 24 h exposure to 1 mM (Z)-1-(N-(2-aminoethyl)-N-(2-ammonioethyl)amino)diazen-1-ium-1,2-diolate leads to both reduction in cGKI expression and specific activity | Sus scrofa |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Sus scrofa | - |
- |
- |
Purification (Comment) | Organism |
---|---|
Ni2+-Sepharose column chromatography | Sus scrofa |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
pulmonary artery | - |
Sus scrofa | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + RKISASEFDRPLR | - |
Sus scrofa | ADP + phosphorylated RKISASEFDRPLR | - |
? |
Synonyms | Comment | Organism |
---|---|---|
cGKI | - |
Sus scrofa |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | - |
Sus scrofa | |
cGMP | dependent, maximal activity at 0.1 mM | Sus scrofa |